Prof Benjamin Thierry is the University of South Australia Professor of Bioengineering and a Research Leader at the Future Industries Institute. He is a NHMRC Investigator Fellow and the Head of the South Australian Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Fellowships. He was awraded in 2020 a NHMRC Investigator Fellowships (Addressing Healthcare Disparities in Remote and Low Resource Settings with Solid-State Biodiagnostic Devices).
Prof Thierry leads the translational Bioengineering group which aims to develop and... Read more
About me
Prof Benjamin Thierry is the University of South Australia Professor of Bioengineering and a Research Leader at the Future Industries Institute. He is a NHMRC Investigator Fellow and the Head of the South Australian Node of the ARC Centre of Excellence in Convergent Bio and Nano Science and Technology (CBNS). He received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two Career Development Fellowships. He was awraded in 2020 a NHMRC Investigator Fellowships (Addressing Healthcare Disparities in Remote and Low Resource Settings with Solid-State Biodiagnostic Devices).
Prof Thierry leads the translational Bioengineering group which aims to develop and implement novel biodiagnostic and prognostic technologies and is currently involved in several clinical translation/commercialization activities. A significant outcome of his research has been the development of a patented cancer staging diagnostic technology that has received substantial commercial interest and investment through a spin-off company, Ferronova Pty Ltd. Ferronova has raised over $3.5 million in 2020 to fund several on-going clinical trials in Australia and the US. Another significant research focus is the development of biodiagnostic technologies aimed at improving prenatal care, especially in rural and low-ressource settings. In close collaboration with industry partners and clinicians, he is leading a comprehensive research program aimed at enabling better detection and treatment of pregnancy complications such as preeclampsia and pre-term birth. He co-founded SanguisDx in 2020 to accelerate the development of his solid-state diagnostic platform. He has also developed and patented a technology aimed at enabling comprehensive non-invasive prenatal genetic testing, which is currently being developed through a NHMRC Development Grant.
With the support of the ARC Centre of Excellence in Convergent Bio and Nano Science, Prof Thierry leads a research program oaimed at the development of next-generation in vitro organ and disease models, including models based on "organs-on-chips" concept and 3D Bioprinting. A specific focus is on patients derived tumour-on-chip models that recapitulate the tumour microenvironment. These models are being used to assist in the development of better cancer therapeutics, including based on ionizing radiation and immunotherapy.
About me
Doctor of Philosophy McGill University
Master of Applied Science Ecole Polytechnique de Montreal
Bachelor of Engineering Institute National Polytechnique de Grenoble
The Bioengineering group aims at bridging the gap between engineering and medicine, with specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
Excludes commercial-in-confidence projects.
AAS - Portable Healthcare: High-Value Micro/Nano-Scale Structures and Coating for Mass Production of Biomedical Devices, Australian Academy of Science, 01/11/2017 - 28/02/2022
Development of Superior Sentinel Lymph Node Mapping Procedures using Magnetic Tracers, NHMRC - Development Grant, 01/01/2019 - 31/12/2021
Detection and viability of waterborne pathogens using a gut-on-chip, ARC - Linkage Project, 12/12/2018 - 11/12/2021
Preoperative Imaging of Metastatic Deposits in Regional Lymph Nodes: Preclinical Validation of a New Staging Modality for Head and Neck Cancer, NHMRC - Project Grant, 01/01/2019 - 31/07/2021
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC - Centre of Excellence, 01/04/2014 - 29/06/2021
Nanoscale silicon field-effect transistor diagnostic technology, ARC - Discovery Projects, 27/03/2017 - 31/12/2020
Development of Superior Sentinel Lymph Node Staging Procedures in Head and Neck Cancer Using Magnetic Tracers, Garnett Passe and Rodney Williams Memorial Foundation - Conjoint Grant, 01/06/2018 - 31/05/2020
Targeting particulate carriers to epithelial M cells, ARC - Linkage Project, 15/12/2015 - 30/09/2019
Advanced technologies for improved molecular diagnostic and prognostic of gastrointestinal cancers, NHMRC - Career Development Fellowship, 01/01/2015 - 31/12/2018
Nanomedicines Immunotargeting: Hitting the Target or Lost In Translation?, NHMRC - Project Grant, 01/01/2013 - 31/12/2016
NHMRC Equip 2015 - Stage-top incubator for live-cell imaging with the Zeiss LSM 710 super-high resolution microscope, NHMRC - Equipment Only Grants, 01/01/2016 - 31/12/2016
A novel nitric oxide-based treatment for recalcitrant Staphylococcus aureus-associated chronic rhinosinusitis (admin by Uni of Adelaide), NHMRC - Project Grant, 01/01/2013 - 30/06/2016
Functional Nanoparticles: Towards Novel Advanced Cancer Diagnostic, Prognostic and Therapeutic Strategies, NHMRC - Career Development Fellowship, 01/01/2010 - 31/12/2014
'The image stream Mark II: a state-of-the-art imaging flow cytometry facility for the detection of rare cancer cells and bioengineering applications, The Ramaciotti Foundations, 15/10/2013 - 14/10/2014
Microfabricated Devices: A significant advance for the detection and molecular analyses of circulating cancer cells?, NHMRC - Project Grant, 01/01/2010 - 31/12/2013
Digital Holographic Microscope: An advanced imaging facility for the development of lab-on-chip devices., The Ramaciotti Foundation - Major Equipment Grant, 01/01/2012 - 31/12/2013
Advanced nanostructured biointerfaces for cell capture, ARC - Discovery Projects, 01/01/2008 - 30/06/2013
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2019 |
19
16
2
|
2019 |
5
2
58
|
2019 |
Open access
8
8
2
|
2019 |
Open access
4
4
1
|
2016 |
Open access
35
32
52
|
Year | Output |
---|---|
2012 |
|
2011 |
|
2009 |
|
Year | Output |
---|---|
2020 |
15
13
5
|
2020 |
1
|
2020 |
Open access
1
|
2020 |
1
1
2
|
2020 |
2
1
1
|
2020 |
2
1
3
|
2020 |
Open access
7
8
4
|
2020 |
Open access
16
14
1
|
2019 |
19
16
2
|
2019 |
5
2
58
|
2019 |
Open access
2
1
4
|
2019 |
11
10
|
2019 |
Open access
8
8
2
|
2019 |
Open access
1
1
3
|
2019 |
Open access
4
4
1
|
2019 |
Open access
17
17
3
|
2019 |
4
4
1
|
2019 |
Open access
|
2019 |
Open access
3
1
3
|
2019 |
2
2
7
|
2018 |
Open access
5
6
1
|
2018 |
Open access
1
1
|
2018 |
Open access
2
1
|
2018 |
1
1
1
|
2018 |
Open access
31
26
8
|
2018 |
Open access
14
15
63
|
2017 |
Open access
10
8
|
2017 |
3
3
1
|
2017 |
13
14
1
|
2017 |
29
29
|
2017 |
1
1
|
2017 |
27
27
|
2016 |
Open access
35
32
52
|
2016 |
22
20
1
|
2016 |
2
|
2016 |
Open access
15
13
3
|
2016 |
5
3
|
2016 |
Open access
25
27
2
|
2016 |
18
20
1
|
2016 |
19
18
|
2015 |
Open access
14
14
|
2015 |
Open access
33
29
|
2015 |
Open access
38
35
4
|
2015 |
Open access
77
74
|
2015 |
29
28
9
|
2015 |
Open access
15
14
1
|
2015 |
16
16
|
2015 |
10
10
|
2015 |
Open access
8
8
3
|
2014 |
36
37
1
|
2014 |
18
19
|
2014 |
Open access
11
10
|
2014 |
18
18
1
|
2014 |
24
23
|
2014 |
Open access
26
24
1
|
2014 |
3
6
|
2014 |
27
24
|
2014 |
20
19
|
2014 |
25
29
6
|
2014 |
4
5
|
2014 |
38
33
|
2014 |
Open access
11
12
|
2014 |
4
3
|
2014 |
94
90
1
|
2014 |
Open access
52
52
5
|
2014 |
23
25
|
2014 |
30
28
2
|
2013 |
Open access
12
11
|
2013 |
27
24
|
2012 |
12
8
2
|
2012 |
41
38
|
2012 |
35
35
3
|
2012 |
29
26
|
2011 |
9
9
|
2011 |
30
27
|
2010 |
68
64
|
2010 |
140
133
|
2010 |
Open access
28
26
|
2010 |
43
39
|
2010 |
40
35
|
2009 |
26
25
|
2009 |
61
|
2009 |
28
24
|
2009 |
25
27
|
2009 |
86
86
|
2008 |
|
2008 |
3
2
|
2008 |
69
68
|
2008 |
74
71
|
2008 |
30
28
|
Year | Output |
---|---|
2015 |
Open access
|
2015 |
1
|
2015 |
2
2
|
2013 |
2
2
|
Research
The Bioengineering group aims at bridging the gap between engineering and medicine, with specific focus on oncology and prenatal diagnostics. To this end, we are developing a range of technologies aimed at providing either basic insights about biological processes or designed to address significant biomedical challenges. More info can be find on our web site: www.bionanoengineering.com.
Current research areas:
Research
Details | Registry | Status |
---|---|---|
Sensor for detection of magnetic particles Cousins, Aidan Mark Francis; Thierry, Benjamin; Wedding, A Bruce; Forero Morales, Daniel |
WO | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Academia Sinica | TAIWAN |
Adelaide Pathology Partners | AUSTRALIA |
Agency for Science, Technology and Research (A*STAR) | SINGAPORE |
Australian National Fabrication Facility Limited | AUSTRALIA |
Australian Nuclear Science and Technology Organisation | AUSTRALIA |
Australian Nuclear Science Technology Organisation | AUSTRALIA |
Australian Synchrotron Company Ltd | AUSTRALIA |
Austrian Institute of Technology | SWITZERLAND |
Bionomics Ltd. | AUSTRALIA |
Boutiq Science Ltd | NEW ZEALAND |
Ceramisphere | AUSTRALIA |
CeramiSphere Pty Ltd | AUSTRALIA |
Children's Cancer Institute Australia | AUSTRALIA |
Chinese Academy of Sciences | CHINA |
CSIRO Australia (Commonwealth Scientific Industrial Research Organisation) | AUSTRALIA |
Curtin University | AUSTRALIA |
Dana-Farber Cancer Institute | UNITED STATES |
Ferronova Pty Ltd Salisbury South | AUSTRALIA |
First Affiliated Hospital of Zhengzhou University | CHINA |
Flinders University | AUSTRALIA |
Forschungszentrum Jülich | GERMANY |
Hanoi University of Science and Technology | VIET NAM |
Hanson Institute | AUSTRALIA |
Harbin Institute of Technology | CHINA |
High Performance Computing | SINGAPORE |
Imperial College of Science, Technology and Medicine | UNITED KINGDOM |
Institute of Medical and Veterinary Science | AUSTRALIA |
Laboratoire de Biologie Moleculaire et de Genie genetique | BELGIUM |
Magnetic Insight | UNITED STATES |
Marinova Pty Ltd | AUSTRALIA |
McGill University | CANADA |
Memorial Sloan Kettering Cancer Centre | UNITED STATES |
Minomic Pty Ltd | AUSTRALIA |
Monash IVF Group | AUSTRALIA |
Monash University | AUSTRALIA |
Montreal Heart Institute | CANADA |
Murdoch University | AUSTRALIA |
Nanjing Agricultural University | CHINA |
Nanjing Forestry University | CHINA |
Nanjing Medical University | CHINA |
Nanyang Technological University | SINGAPORE |
National Center for Technological Progress | VIET NAM |
Peter Grunberg Institute (PGI) | GERMANY |
Prince of Wales Hospital | AUSTRALIA |
Private Individual | AUSTRALIA |
Queen Elizabeth Hospital | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Repromed | AUSTRALIA |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Adelaide Hospital Cancer Centre | AUSTRALIA |
SA Pathology | AUSTRALIA |
SA Water Corporation | AUSTRALIA |
Sechenov First Moscow State Medical University | RUSSIAN FEDERATION |
Shanghai Jiao Tong University | CHINA |
Soochow Uiniversity | CHINA |
Southeast University | CHINA |
Southern Medical University | CHINA |
St George Hospital | AUSTRALIA |
Stanford University | UNITED STATES |
Sung Kyun Kwan University | KOREA, REPUBLIC OF (SOUTH) |
Swiss Federal Institute of Technology Zurich (ETH) | SWITZERLAND |
Tabasco Advance Science and Technology Research Center | MEXICO |
Tabriz University of Medical Sciences | IRAN |
Tabsco Center for Applied Science and Technology Research | MEXICO |
Technical University Munich | GERMANY |
Universita degli Studi di Pavia (AKA Institute for Advanced Study of Pavia) | ITALY |
University College Dublin | IRELAND |
University of Adelaide | AUSTRALIA |
University of California, Berkeley | UNITED STATES |
University of Canterbury | NEW ZEALAND |
University of Edinburgh | UNITED KINGDOM |
University of Helsinki | FINLAND |
University of Melbourne | AUSTRALIA |
University of Montreal | CANADA |
University of New South Wales | AUSTRALIA |
University of Nottingham | UNITED KINGDOM |
University of Oulu | FINLAND |
University of Pavia | ITALY |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Tokyo | JAPAN |
University of Toronto | CANADA |
University of Warwick | UNITED KINGDOM |
University of Wisconsin-Madison | UNITED STATES |
WARTN | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
Yangzhou University | CHINA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2018 |
Panel member, Early Career Fellowship SchemeNational Health and Medical Research Council (NHMRC) |
2015 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2014 |
Expert panel member, Program Grant SchemeNational Health and Medical Research Council (NHMRC) |
2014 |
Best paper award, Wafer-Scale Fabrication of Ultra-Thin Silicon Nanowire Devices13th IEEE International Conference on Nanotechnology, Beijing |
2013 |
Panel member, Project Grants Peer Review ProcessNational Health and Medical Research Council (NHMRC) |
2012 |
Career Development FellowshipNational Health and Medical Research Council (NHMRC) |
2010 |
Prof Thierry is the head of the BioEngineering group at the UniSA Future Industries Institute. The group is hosted in the state-of-the-art MM building and is a dynamic multidisciplinary team with expertise in physics, nanoscience, pharmaceutical science, molecular biology and biomedical engineering. The group has a strong network of collaborators including with prestigious international research institutions such as the University of Stanford, the University of Tokyo, the Beijing CAS Centre for Nanoscience and Technology, the Forschungszentrum Juelich, Harvard University Dana-Farber Cancer Institute and McGill University. Several current and past members of the group have received prestigious awards, inluding a 2019 Tall Poppy award (Dr. Marnie Winter), a Women in Technology Rising Star Award (Dr Michelle Liu) and a finalist award in the 2018 Prime Minister’s Prizes for Science (Dr Aidan Cousins).
Prof Thierry served as the Program Coordinator of the UniSA NanoBioMaterials Honours degree from 2010 to 2017. He is also teaching in various undergraduate and postgraduate programs, including Monash University and SouthEast University (Nanjing, China).
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Characterizing the role of intestinal M cells in the transport of nanoparticles in an advanced microfluidic model of the small intestinal follicle-associated epithelium | Current |
Development of a lab-on-chip technology for single cell whole genome amplification | Current |
Development of a wearable electrocardiogram nanosensor for screening hypertensive pregnancy complications | Current |
Development of imaging methods/models to study oral vaccination and/or delivery of biologics | Current |
Development of nanomedicines for the radiosensitization of proton beam therapy | Current |
Dielectric resonator antenna sensor for infrastructure health monitoring application | Current |
In vivo manufacturing of CAR-T cells using targeted non-viral nanocarriers | Current |
Microfluidic manufacturing of chimeric anitgen receptor t cells | Current |
Next generation bioengineered in vitro tumour models | Current |
Organs-on-Chips for Infectious Diseases | Current |
Solid state biosensors with adjustable dynamic range towards Point of Care diagnostics prognostics of infectious disease | Current |
The role of metal nanoparticles and the metal core/metal oxinde shell structure when utilised as radiosensitisers in X-ray radiation therapy | Current |
Understanding and targeting preeclampsia molecular mechanisms for improved pregnancy outcomes. | Current |
Amplification of surface plasmon resonance biomolecular binding events: towards improved biosensing based cancer prognostics | Completed |
Bioengineered vascularized microfluidic model: towards improved cancer therapy risk reduction and in vitro evaluation of the metastatic process | Completed |
Cation exchange reaction in colloidal nanocrystals: a versatile approach towards improved cancer imaging and radiotherapy | Completed |
Detection and characterisation of rare disseminated cancer cells; towards improved patient prognostication | Completed |
Development of a solid-state biodiagnostic platform based on indium oxide nanoribbon field effect transistors | Completed |
Formation and characterisation of fucoidan-based polyelectrolyte multilayers for applications in biomaterials | Completed |
Improving nitric oxide delivery to staphylococcus aureus biofilms | Completed |
Isolation and analysis of circulating fetal cells: towards improved non-invasive prenatal diagnosis of genetic disorders | Completed |
Long-range surface plasmon resonance biosensing structures for mammalian-cell studies | Completed |
Microfluidic intestine-on-a-chip in vitro models for improved mechanistic understanding of intestinal drug and particulate carrier uptake | Completed |
Microfluidic intestine-on-a-chip in vitro models for improved understanding of intestinal particulate carrier absorption and interaction with mucus | Completed |
Novel fabrication and operation of integrated silicon nanowire field effect biosensors for reliable detection of cancer prognostic biomarkers | Completed |
Novel handheld magnetometer probe for improved intraoperative detection of sentinel lymph nodes in cancer patients | Completed |
Radiosensitization of cell sub-populations by gold nanoparticles: cross-correlative microscopy for elucidating fundamental mechanisms | Completed |
Transport of immuno-targeted nanoparticles in 3D tumor spheroids and in vivo models | Completed |